bupropion has been researched along with 2019 Novel Coronavirus Disease in 5 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We used interrupted time series modelling to quantify the impact of COVID-19 on dispensing of nicotine replacement therapy (NRT) patches, varenicline and all smoking cessation treatments combined separately." | 4.31 | Publicly subsidised smoking cessation medicines in times of COVID-19 in Australia: An interrupted time series analysis. ( Baliunas, D; Comans, T; Gartner, C; Hollingworth, SA; Pole, JD; Sullivan, C, 2023) |
| " They were given bupropion extended release and though varied with dosing and time to resolution, they recovered dramatically." | 1.91 | Can bupropion treat COVID-19-induced brain fog? A case series. ( Reinfeld, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tattan-Birch, H | 1 |
| Kock, L | 1 |
| Brown, J | 1 |
| Beard, E | 1 |
| Bauld, L | 1 |
| West, R | 1 |
| Shahab, L | 1 |
| Reinfeld, S | 1 |
| Baliunas, D | 1 |
| Gartner, C | 1 |
| Hollingworth, SA | 1 |
| Sullivan, C | 1 |
| Comans, T | 1 |
| Pole, JD | 1 |
| Davis, JM | 1 |
| Masclans, L | 1 |
| Rose, JE | 1 |
| Allen, S | 1 |
| Thomas, J | 1 |
| Harrison, K | 1 |
| Emery, RL | 1 |
| Petersen, A | 1 |
| Winickoff, JP | 1 |
| Japuntich, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Bupropion for the Prevention of Postpartum Smoking Relapse[NCT04098874] | Phase 4 | 200 participants (Anticipated) | Interventional | 2020-01-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for bupropion and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
E-cigarettes to Augment Stop Smoking In-person Support and Treatment With Varenicline (E-ASSIST): A Pragmatic Randomized Controlled Trial.
Topics: Adult; Bupropion; COVID-19; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Smokin | 2023 |
Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial.
Topics: Bupropion; COVID-19; Female; Humans; Male; Middle Aged; Nicotine; Pandemics; Smoking Cessation; Toba | 2023 |
Bupropion for postpartum smoking relapse: A remote protocol for a two-arm, double-blind, placebo-controlled randomized clinical trial.
Topics: Antidepressive Agents; Bupropion; COVID-19; Delayed-Action Preparations; Depressive Disorder; Depres | 2021 |
2 other studies available for bupropion and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Can bupropion treat COVID-19-induced brain fog? A case series.
Topics: Brain; Bupropion; COVID-19; Dopamine; Humans; Mental Disorders | 2023 |
Publicly subsidised smoking cessation medicines in times of COVID-19 in Australia: An interrupted time series analysis.
Topics: Bupropion; COVID-19; Humans; Interrupted Time Series Analysis; Nicotine; Nicotinic Agonists; Pandemi | 2023 |